查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1739311

全球人工智慧医疗诊断工具市场

Artificial Intelligence-based Medical Diagnostic Tools
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2030年，全球人工智慧医疗诊断工具市场规模将达48亿美元

全球人工智慧医疗诊断工具市场规模预计在2024年为17亿美元，预计到2030年将达到48亿美元，2024年至2030年的复合年增长率为19.0%。人工智慧软体是本报告分析的细分市场之一，预计其复合年增长率为19.6%，到分析期结束时规模将达到23亿美元。人工智慧服务细分市场在分析期间的复合年增长率预计为17.4%。

美国市场规模估计为 4.457 亿美元，中国市场预计复合年增长率为 17.9%

美国基于人工智慧的医疗诊断工具市场规模预计在2024年达到4.457亿美元。预计到2030年，作为世界第二大经济体的中国市场规模将达到7.393亿美元，在2024-2030年的分析期内，复合年增长率为17.9%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为17.4%和16.3%。在欧洲，预计德国市场的复合年增长率约为12.9%。

全球基于人工智慧的医疗诊断工具市场—主要趋势与驱动因素摘要

为什么基于人工智慧的诊断工具正在重塑医疗决策

基于人工智慧的医疗诊断工具正在改变临床工作流程和医疗服务，为众多医学学科提供快速、准确且可扩展的诊断支援。这些工具利用机器学习 (ML)、深度学习和自然语言处理 (NLP) 分析各种临床数据，包括放射影像、病理切片、基因组序列、电子健康记录(EHR) 和实验室检测结果，从而识别模式、检测异常并产生鑑别诊断，其一致性和速度均高于传统方法。随着全球医疗系统努力应对日益增长的患者数量、人力短缺以及精准医疗的需求，人工智慧诊断正逐渐成为提高诊断准确性和减少护理差异的重要辅助。

与依赖静态规则集的传统决策支援系统不同，人工智慧工具透过研究通常由专家註释的大型资料集不断学习和发展，从而即时提供基于证据的洞察。这些系统正被整合到放射科实验室、病理科实验室、基层医疗诊所和远端医疗平台中，以支援早期疾病检测、分流和风险分层。从肿瘤科、循环系统到眼科、皮肤科，人工智慧能够快速识别复杂的病理，减少诊断延迟，提高临床效率，并促进及时干预，从而改善患者预后。

人工智慧演算法如何提高成像、基因组学和多模态数据的诊断效能？

以人工智慧为基础的诊断工具正在透过高精度解读电脑断层扫描、核磁共振成像 (MRI)、X 光、乳房 X 光检查和超音波影像，彻底革新医学影像。深度卷积类神经网路(CNN) 广泛应用于影像分割、特征提取和病变分类，在肺结节检测、乳癌筛检和糖尿病视网膜病变分级等特定任务中，其表现往往优于人类专家。这些工具不仅加快了影像解读速度，还能透过热图和可解释的特征来突显异常情况，进而提高临床可靠性和工作流程整合度。

在基因组学领域，人工智慧正在帮助解读复杂的基因数据，从而辅助肿瘤疾病风险预测、罕见疾病诊断和治疗方法选择。自然语言处理演算法能够从非结构化的电子健康檔案 (EHR)、实验室报告和临床记录中提取临床相关数据，从而创建全面的患者檔案，并检测出人工审核可能遗漏的诊断讯号。结合影像、实验室值、基因标记和患者病历的多模态人工智慧模型因其能够产生全面的诊断见解和个人化治疗建议而日益受到重视。这些进步正在推动诊断工具超越单一模态的精准诊断，迈向支持基于价值、数据驱动医疗的整合精准诊断。

哪些市场需求正在加速成长，哪些临床领域正在引领人工智慧诊断的应用？

受医疗保健数位化不断提高、政策对人工智慧整合的支持以及临床医生接受度不断提高的推动，美国、欧洲和亚太地区对基于人工智慧的医疗诊断工具的需求正在迅速增长。北美在采用方面处于领先地位，这得益于先进的医疗IT基础设施、优惠的报销试点以及充满活力的新兴企业、学术机构和监管途径（例如 FDA 基于人工智慧/机器学习的软体即医疗器材框架）的生态系统。在欧洲，透过国家医疗保健系统和欧盟支持的创新计划，采用率正在不断增长。在亚太地区，官民合作关係关係和以人工智慧为中心的医疗改革的推动，中国、韩国、日本和印度等国家正在医院和诊断实验室加速采用人工智慧。

放射学仍然是最活跃的应用领域，人工智慧工具解决了诊断积压问题并实现了远端成像。病理学和肿瘤学是主要的成长领域，人工智慧可协助进行肿瘤分类、突变分析和切片检查分析。在循环系统，人工智慧正被用于心电图解读、心臟衰竭风险预测和基于影像的结构评估。在眼科和皮肤科领域，人工智慧正被用于糖尿病眼部筛检和皮肤病变分析，通常采用行动和云端基础解决方案。感染疾病检测（例如新冠肺炎、结核病）和照护现场的新兴应用正在惠及农村和服务不足的医疗机构，这些机构的临床医生短缺问题持续存在。

是什么推动了基于人工智慧的医疗诊断工具的全球成长？

基于人工智慧的医疗诊断工具的成长源于医疗数位化的整合、日益加重的慢性病负担，以及对及时、经济高效的大规模诊断的需求。关键驱动因素是结构化和非结构化临床数据的日益普及，加上云端运算、边缘人工智慧和联邦学习的进步，从而实现了跨医疗环境的安全、可扩展部署。这些工具减少了诊断错误，提高了临床诊疗效率，并实现了早期疗育。

监管机构正在不断发展，透过自适应核准途径、实际检验要求和上市后绩效监测来支援人工智慧的整合。人工智慧工具也正作为电子健康檔案 (EHR)、影像与远端医疗平台中的整合临床决策支援系统 (CDSS) 而日益普及，从而推动了其易用性和临床应用。随着医疗科技公司、付款人和提供者网路加大对人口健康、个人化医疗和远距医疗就诊的人工智慧诊断的投资，一个关键问题正在浮现：基于人工智慧的诊断工具能否实现广泛的临床可靠性、互通性和公平的可及性，从而重新定义及时准确的医疗诊断的全球标准？

部分

组件（软体、服务、硬体、记忆体、其他组件）；应用（放射学、心臟病学、神经病学、肿瘤学、其他应用）；垂直行业（医院、诊断实验室、其他垂直行业）

受访企业范例（共42家）

  • Ada Health
  • Aidmed
  • Aidoc
  • Aiforia
  • AliveCor
  • Bay Labs
  • Behold.ai
  • Butterfly Network
  • Caption Health
  • Cardiologs
  • Cleerly
  • DeepMind Health
  • Digital Diagnostics
  • Eko Health
  • Enlitic
  • GE Healthcare
  • Ibex Medical Analytics
  • InferVision
  • Lunit
  • Medtronic

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口（成品和原始OEM）来预测其竞争地位的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括人为提高销货成本、盈利下降、供应链重组以及其他微观和宏观市场动态。

全球产业分析师密切关注来自全球顶尖首席经济学家（14,949位）、智库（62家）以及贸易和产业协会（171家）的专家的意见，以评估其对生态系统的影响并应对新的市场现实。我们追踪了来自每个主要国家的专家和经济学家对关税及其对本国影响的看法。

全球产业分析师预计，这场动盪将在未来2-3个月内逐渐平息，新的世界秩序将更加清晰地建立。全球产业分析师正在即时追踪这些事态发展。

2025年4月：谈判阶段

在4月的报告中，我们将探讨关税对全球整体市场的影响，并提供区域市场调整。我们的预测是基于历史数据和不断变化的市场影响因素。

2025年7月：最终关税调整

在各国宣布最终重置后，客户将在 7 月收到免费更新，最终更新将包含明确的关税影响分析。

相互和双边贸易及关税影响分析：

美国<>中国<>墨西哥<>加拿大<>欧盟<>日本<>印度<>其他176个国家

领先的产业经济学家：全球产业分析师知识库追踪了 14,949 位经济学家，其中包括来自民族国家、智库、贸易和产业协会、大型企业以及各领域专家的最具影响力的首席经济学家，他们共用了这场前所未有的全球经济状况模式转移的影响。我们超过 16,491 份报告大多遵循基于里程碑的两阶段发布计划。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 竞赛

简介目录
Product Code: MCP33471

Global Artificial Intelligence-based Medical Diagnostic Tools Market to Reach US$4.8 Billion by 2030

The global market for Artificial Intelligence-based Medical Diagnostic Tools estimated at US$1.7 Billion in the year 2024, is expected to reach US$4.8 Billion by 2030, growing at a CAGR of 19.0% over the analysis period 2024-2030. AI Software, one of the segments analyzed in the report, is expected to record a 19.6% CAGR and reach US$2.3 Billion by the end of the analysis period. Growth in the AI Services segment is estimated at 17.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$445.7 Million While China is Forecast to Grow at 17.9% CAGR

The Artificial Intelligence-based Medical Diagnostic Tools market in the U.S. is estimated at US$445.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$739.3 Million by the year 2030 trailing a CAGR of 17.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 17.4% and 16.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.9% CAGR.

Global Artificial Intelligence-Based Medical Diagnostic Tools Market - Key Trends & Drivers Summarized

Why Are AI-Based Diagnostic Tools Reshaping the Medical Decision-Making Landscape?

Artificial Intelligence-based medical diagnostic tools are transforming clinical workflows and healthcare delivery by providing fast, accurate, and scalable diagnostic support across a broad spectrum of medical disciplines. These tools leverage machine learning (ML), deep learning, and natural language processing (NLP) to analyze diverse clinical data-including radiology images, pathology slides, genomic sequences, electronic health records (EHRs), and laboratory test results-to identify patterns, detect anomalies, and generate differential diagnoses with greater consistency and speed than traditional methods. As healthcare systems worldwide grapple with rising patient volumes, workforce shortages, and the demand for precision medicine, AI-powered diagnostics are emerging as indispensable aids for improving diagnostic accuracy and reducing variability in care.

Unlike conventional decision-support systems that rely on static rule sets, AI tools continuously learn and evolve by training on large datasets, often annotated by experts, to provide real-time, evidence-based insights. These systems are being integrated into radiology suites, pathology labs, primary care practices, and telehealth platforms to support early disease detection, triage, and risk stratification. From oncology and cardiology to ophthalmology and dermatology, AI is enabling faster identification of complex conditions-reducing diagnostic delays, enhancing clinical productivity, and facilitating timely interventions that improve patient outcomes.

How Are AI Algorithms Enhancing Diagnostic Performance Across Imaging, Genomics, and Multimodal Data?

AI-based diagnostic tools are revolutionizing medical imaging by interpreting CT scans, MRIs, X-rays, mammograms, and ultrasound images with high precision. Deep convolutional neural networks (CNNs) are widely used for image segmentation, feature extraction, and lesion classification, often outperforming human specialists in specific tasks such as lung nodule detection, breast cancer screening, and diabetic retinopathy grading. These tools not only accelerate image interpretation but also highlight abnormalities with heat maps and explainability features that improve clinical confidence and workflow integration.

In genomics, AI is helping decode complex genetic data for disease risk prediction, rare disease diagnosis, and therapy selection in oncology. Natural language processing algorithms extract clinically relevant data from unstructured EHRs, lab reports, and clinical notes to create comprehensive patient profiles and detect diagnostic signals that may be missed in manual review. Multimodal AI models, which combine imaging, lab values, genetic markers, and patient history, are gaining prominence for their ability to generate holistic diagnostic insights and personalized treatment recommendations. These advances are pushing diagnostic tools beyond single-modality accuracy toward integrative precision diagnostics that support value-based, data-driven care.

Where Is Market Demand Accelerating and Which Clinical Segments Are Leading AI Diagnostic Adoption?

Demand for AI-based medical diagnostic tools is expanding rapidly across the U.S., Europe, and Asia-Pacific, driven by rising healthcare digitization, policy support for AI integration, and growing acceptance among clinicians. North America leads in adoption, supported by advanced health IT infrastructure, favorable reimbursement pilots, and an active ecosystem of medtech startups, academic institutions, and regulatory pathways (e.g., FDA’s AI/ML-based Software as a Medical Device framework). Europe is witnessing increased uptake through national health systems and EU-backed innovation programs. In Asia-Pacific, countries like China, South Korea, Japan, and India are accelerating deployment in hospitals and diagnostics labs, aided by public-private partnerships and AI-centric healthcare reforms.

Radiology remains the most active application area, where AI tools are addressing diagnostic backlogs and enabling teleradiology. Pathology and oncology are key growth segments, with AI aiding in tumor classification, mutation profiling, and biopsy analysis. Cardiology is leveraging AI for ECG interpretation, heart failure risk prediction, and imaging-based structural assessments. Ophthalmology and dermatology are deploying AI for diabetic eye screening and skin lesion analysis, often via mobile or cloud-based solutions. Emerging applications in infectious disease detection (e.g., COVID-19, TB) and point-of-care diagnostics are expanding reach into underserved and rural healthcare environments, where clinician shortages persist.

What Is Driving the Global Growth of AI-Based Medical Diagnostic Tools?

The growth in artificial intelligence-based medical diagnostic tools is driven by the convergence of healthcare digitalization, rising chronic disease burden, and the need for timely, cost-effective diagnostics at scale. A key driver is the increasing availability of structured and unstructured clinical data, coupled with advances in cloud computing, edge AI, and federated learning, which allow for secure, scalable deployment across care settings. These tools reduce diagnostic errors, improve clinical throughput, and enable earlier interventions-aligning with global goals of achieving better outcomes while reducing healthcare costs.

Regulatory bodies are evolving to support AI integration through adaptive approval pathways, real-world validation requirements, and post-market performance monitoring. AI tools are also gaining traction as clinical decision-support systems (CDSS) integrated within EHRs, PACS, and telehealth platforms-enhancing their usability and clinical adoption. As medtech companies, payers, and provider networks increasingly invest in AI diagnostics for population health, personalized medicine, and remote care, a pivotal question surfaces: Can AI-based diagnostic tools achieve widespread clinical trust, interoperability, and equitable access to redefine global standards for timely and precise medical diagnosis?

SCOPE OF STUDY:

The report analyzes the Artificial Intelligence-based Medical Diagnostic Tools market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Software, Services, Hardware, Memory, Other Components); Application (Radiology, Cardiology, Neurology, Oncology, Other Applications); Vertical (Hospitals, Diagnostic Laboratories, Other Verticals)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • Ada Health
  • Aidmed
  • Aidoc
  • Aiforia
  • AliveCor
  • Bay Labs
  • Behold.ai
  • Butterfly Network
  • Caption Health
  • Cardiologs
  • Cleerly
  • DeepMind Health
  • Digital Diagnostics
  • Eko Health
  • Enlitic
  • GE Healthcare
  • Ibex Medical Analytics
  • InferVision
  • Lunit
  • Medtronic

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Artificial Intelligence-based Medical Diagnostic Tools - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Early Detection Capabilities Position AI Diagnostic Tools as Frontline Screening Technologies
    • Integration With Imaging Modalities Enhances Diagnostic Accuracy in Radiology and Pathology
    • AI-Based Tools Support Faster Triage and Clinical Decision-Making in Overburdened Healthcare Systems
    • Explainable AI Models Increase Physician Trust in Medical Diagnostic Algorithms
    • Expansion in Cloud-Based Platforms Drives Scalability of AI Diagnostic Tools Across Hospitals
    • Multi-Disease Screening Algorithms Enable Versatile Deployment of AI Medical Diagnostics
    • AI Integration Reduces Diagnostic Error Rates in Complex and Rare Disease Cases
    • Regulatory Approvals for AI Diagnostic Tools Expand Clinical Use in Primary and Secondary Care
    • Workflow Integration With EHRs and PACS Systems Boosts Adoption of AI Diagnostic Technologies
    • Consumer-Facing AI Tools Bridge Gaps in Access to Specialist Diagnostics
    • Telehealth Platforms Leverage AI Diagnostics for Real-Time Remote Evaluation
    • Cross-Specialty Application Potential Strengthens the Long-Term Value of AI-Based Diagnostic Tools
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Artificial Intelligence-based Medical Diagnostic Tools Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Hardware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Hardware by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Memory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Memory by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Other Components by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Other Components by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Radiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Radiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Other Verticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for Other Verticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Artificial Intelligence-based Medical Diagnostic Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 30: USA Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Component - Software, Services, Hardware, Memory and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Component - Percentage Breakdown of Value Sales for Software, Services, Hardware, Memory and Other Components for the Years 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Application - Other Applications, Radiology, Cardiology, Neurology and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Application - Percentage Breakdown of Value Sales for Other Applications, Radiology, Cardiology, Neurology and Oncology for the Years 2025 & 2030
    • TABLE 34: USA Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Hospitals, Diagnostic Laboratories and Other Verticals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: USA 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other Verticals for the Years 2025 & 2030
  • CANADA
    • TABLE 36: Canada Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Component - Software, Services, Hardware, Memory and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Canada 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Component - Percentage Breakdown of Value Sales for Software, Services, Hardware, Memory and Other Components for the Years 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Application - Other Applications, Radiology, Cardiology, Neurology and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Application - Percentage Breakdown of Value Sales for Other Applications, Radiology, Cardiology, Neurology and Oncology for the Years 2025 & 2030
    • TABLE 40: Canada Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Hospitals, Diagnostic Laboratories and Other Verticals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Canada 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other Verticals for the Years 2025 & 2030
  • JAPAN
    • Artificial Intelligence-based Medical Diagnostic Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 42: Japan Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Component - Software, Services, Hardware, Memory and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Japan 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Component - Percentage Breakdown of Value Sales for Software, Services, Hardware, Memory and Other Components for the Years 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Application - Other Applications, Radiology, Cardiology, Neurology and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Application - Percentage Breakdown of Value Sales for Other Applications, Radiology, Cardiology, Neurology and Oncology for the Years 2025 & 2030
    • TABLE 46: Japan Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Hospitals, Diagnostic Laboratories and Other Verticals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Japan 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other Verticals for the Years 2025 & 2030
  • CHINA
    • Artificial Intelligence-based Medical Diagnostic Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 48: China Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Component - Software, Services, Hardware, Memory and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: China 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Component - Percentage Breakdown of Value Sales for Software, Services, Hardware, Memory and Other Components for the Years 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Application - Other Applications, Radiology, Cardiology, Neurology and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Application - Percentage Breakdown of Value Sales for Other Applications, Radiology, Cardiology, Neurology and Oncology for the Years 2025 & 2030
    • TABLE 52: China Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Hospitals, Diagnostic Laboratories and Other Verticals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: China 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other Verticals for the Years 2025 & 2030
  • EUROPE
    • Artificial Intelligence-based Medical Diagnostic Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 54: Europe Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 55: Europe 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Component - Software, Services, Hardware, Memory and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Component - Percentage Breakdown of Value Sales for Software, Services, Hardware, Memory and Other Components for the Years 2025 & 2030
    • TABLE 58: Europe Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Application - Other Applications, Radiology, Cardiology, Neurology and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Europe 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Application - Percentage Breakdown of Value Sales for Other Applications, Radiology, Cardiology, Neurology and Oncology for the Years 2025 & 2030
    • TABLE 60: Europe Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Hospitals, Diagnostic Laboratories and Other Verticals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Europe 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other Verticals for the Years 2025 & 2030
  • FRANCE
    • Artificial Intelligence-based Medical Diagnostic Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Component - Software, Services, Hardware, Memory and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Component - Percentage Breakdown of Value Sales for Software, Services, Hardware, Memory and Other Components for the Years 2025 & 2030
    • TABLE 64: France Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Application - Other Applications, Radiology, Cardiology, Neurology and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: France 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Application - Percentage Breakdown of Value Sales for Other Applications, Radiology, Cardiology, Neurology and Oncology for the Years 2025 & 2030
    • TABLE 66: France Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Hospitals, Diagnostic Laboratories and Other Verticals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: France 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other Verticals for the Years 2025 & 2030
  • GERMANY
    • Artificial Intelligence-based Medical Diagnostic Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Component - Software, Services, Hardware, Memory and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Component - Percentage Breakdown of Value Sales for Software, Services, Hardware, Memory and Other Components for the Years 2025 & 2030
    • TABLE 70: Germany Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Application - Other Applications, Radiology, Cardiology, Neurology and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Germany 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Application - Percentage Breakdown of Value Sales for Other Applications, Radiology, Cardiology, Neurology and Oncology for the Years 2025 & 2030
    • TABLE 72: Germany Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Hospitals, Diagnostic Laboratories and Other Verticals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Germany 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other Verticals for the Years 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Component - Software, Services, Hardware, Memory and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Component - Percentage Breakdown of Value Sales for Software, Services, Hardware, Memory and Other Components for the Years 2025 & 2030
    • TABLE 76: Italy Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Application - Other Applications, Radiology, Cardiology, Neurology and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Italy 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Application - Percentage Breakdown of Value Sales for Other Applications, Radiology, Cardiology, Neurology and Oncology for the Years 2025 & 2030
    • TABLE 78: Italy Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Hospitals, Diagnostic Laboratories and Other Verticals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Italy 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other Verticals for the Years 2025 & 2030
  • UNITED KINGDOM
    • Artificial Intelligence-based Medical Diagnostic Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Component - Software, Services, Hardware, Memory and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Component - Percentage Breakdown of Value Sales for Software, Services, Hardware, Memory and Other Components for the Years 2025 & 2030
    • TABLE 82: UK Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Application - Other Applications, Radiology, Cardiology, Neurology and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: UK 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Application - Percentage Breakdown of Value Sales for Other Applications, Radiology, Cardiology, Neurology and Oncology for the Years 2025 & 2030
    • TABLE 84: UK Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Hospitals, Diagnostic Laboratories and Other Verticals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: UK 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other Verticals for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Component - Software, Services, Hardware, Memory and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Component - Percentage Breakdown of Value Sales for Software, Services, Hardware, Memory and Other Components for the Years 2025 & 2030
    • TABLE 88: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Application - Other Applications, Radiology, Cardiology, Neurology and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Rest of Europe 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Application - Percentage Breakdown of Value Sales for Other Applications, Radiology, Cardiology, Neurology and Oncology for the Years 2025 & 2030
    • TABLE 90: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Hospitals, Diagnostic Laboratories and Other Verticals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Rest of Europe 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other Verticals for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Artificial Intelligence-based Medical Diagnostic Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Component - Software, Services, Hardware, Memory and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Component - Percentage Breakdown of Value Sales for Software, Services, Hardware, Memory and Other Components for the Years 2025 & 2030
    • TABLE 94: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Application - Other Applications, Radiology, Cardiology, Neurology and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Asia-Pacific 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Application - Percentage Breakdown of Value Sales for Other Applications, Radiology, Cardiology, Neurology and Oncology for the Years 2025 & 2030
    • TABLE 96: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Hospitals, Diagnostic Laboratories and Other Verticals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Asia-Pacific 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other Verticals for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Component - Software, Services, Hardware, Memory and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of World 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Component - Percentage Breakdown of Value Sales for Software, Services, Hardware, Memory and Other Components for the Years 2025 & 2030
    • TABLE 100: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Application - Other Applications, Radiology, Cardiology, Neurology and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Rest of World 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Application - Percentage Breakdown of Value Sales for Other Applications, Radiology, Cardiology, Neurology and Oncology for the Years 2025 & 2030
    • TABLE 102: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Hospitals, Diagnostic Laboratories and Other Verticals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Rest of World 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other Verticals for the Years 2025 & 2030

IV. COMPETITION